Harvard Business Review

FEBRUARY 15, 2012

While Guangdong's exports accounted for as much as 37% of China's exports by 2000, its share dropped to 28% in 2011. The province's exports growth rate, which was 26% in 2010, fell to 22% in the first nine months of 2011, and it has continued to decline ever since. Look at the data.

GDP 12

GDP Pharmaceuticals Long-term Globalization 12

Harvard Business Review

NOVEMBER 8, 2017

The health care system in the United States, with its technological prowess and massive infrastructure, often serves as a reference point for rapidly developing economies around the world while they build their own medical systems. Over the same period, pharmaceutical exports have doubled. Victor Albrow/Getty Images. Insight Center.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

AUGUST 17, 2012

Cipla, an India-based producer of low cost antiretroviral drugs (ARVs) is one of the biggest success stories in the pharma industry. What's more, these are markets that traditional developed market firms are increasingly targeting for their own growth goals. and other traditionally developed markets.

Company 11

Company Pharmaceuticals Business Model Fixed Costs 11

Harvard Business Review

DECEMBER 27, 2016

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. But we would argue that credibility may also be signaled to important external stakeholders — future employees, patients, the pharmaceutical industry, donors, and so on.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

JUNE 16, 2016

By the mid-1980’s, the American semiconductor industry seemed like it was doomed. So in 1986, the American government created SEMATECH , a consortium of government agencies, research institutions and private industry. The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. Daniela Saltzman is an MBA student at HBS, class of 2011. As Dean Lu explained, "In China we are committed to economic growth in a way that contributes to companies and a society that are sustainable over the long term.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

FEBRUARY 24, 2015

The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

JUNE 29, 2015

Maybe you remember how savagely the industry was portrayed during the 2012 U.S. Amess, Stiebale, and Wright gathered information from three different databases—one on firm characteristics like sales and industry type, one on LBO deals, and one on patent applications and citations. that didn’t undergo buyouts.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

DECEMBER 14, 2015

Mindfulness is quickly following yoga in becoming a billion-dollar industry. “Thanks to meditation I have developed patience.” A colleague had developed a cutting-edge medical device, but the company he had started to develop and sell the device was on the rocks. Patrick Pilz. ” Archana says.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2013

When we interviewed 45 such people across 39 companies in 8 industries in the United States and Europe, we found that by identifying low-value tasks to either drop completely, delegate to someone else or outsource, the average worker gained back roughly one day a week they could use for more important tasks.

Productivity 8

Productivity Products Peer Review Short-term 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 20, 2015

Until a few years ago Steve Cronce’s Raphael Industries did $1 million dollars a year of specialized industrial painting for customers within driving distance of their plant in Milwaukee, Wisconsin. Global supply chains can cut across many “cultures”: national, industry, technology, market segment, and more.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 10, 2013

But such expectations are unrealistic in many industries. The pressure on the company by the investing community (among others) was so severe that it eventually split into two, Motorola Mobility and Motorola Solutions in January of 2011. The venture capital industry has now become fairly large and robust.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

SEPTEMBER 11, 2014

Although uncertainty is accelerating, it isn’t affecting all industries the same way. and technological uncertainty (can we make a desirable solution?) — and how much uncertainty your industry faces depends on the interaction of the two. As the overall rate of invention across industries increases, so does technological uncertainty.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

MAY 25, 2017

In 2011 81 digital health startups received venture funding; with consistent year-over-year increases, 296 startups were venture backed in 2016. The venture industry is betting big on digital health, with $4–$5 billion invested annually.

Health Care 9

Health Care Trends Venture Funding Technology 9